Vascular Biogenics Ltd (NASDAQ:VBLT)

1.25
Delayed Data
As of May 17
 -0.05 / -3.85%
Today’s Change
0.60
Today|||52-Week Range
3.10
+28.87%
Year-to-Date

Today’s Trading

Previous close1.30
Today’s open1.30
Day’s range1.25 - 1.31
Volume50,023
Average volume (3 months)132,487
Market cap$45.9M
Data as of 3:55pm ET, 05/17/2019

Growth & Valuation

Earnings growth (last year)-67.70%
Earnings growth (this year)+14.52%
Earnings growth (next 5 years)--
Revenue growth (last year)-95.78%
P/E ratioNM
Price/Sales54.67
Price/Book0.87

Competitors

 Today’s
change
Today’s
% change
EVGNEvogene Ltd+0.04+2.29%
ICCCImmuCell Corp-0.08-1.27%
BPTHBio Path Holdings In...-1.23-7.34%
CLSNCelsion Corp-0.01-0.47%
Data as of 3:59pm ET, 05/17/2019

Financials

Next reporting dateAugust 15, 2019
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$585.0K
Annual profit (last year)-$20.5M
Net profit margin-3,497.09%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Dror Harats
Vice President-Research &
Operations
Eyal Breitbart
Corporate headquarters
Modi'in, Jerusalem

Forecasts